相关实验视频

Updated: Jul 6, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

推进诱导多能干细胞依赖细胞替代疗法的挑战

Alan B Moy^1,2, Anant Kamath¹, Sara Ternes¹

¹Cellular Engineering Technologies, Inc. Coralville, IA, 52241.

Medical research archives

|January 8, 2024

概括

诱导多能干细胞 (iPSC) 提供再生医学潜力,但面临着重大的安全和技术障碍. 解决重编程,遗传稳定性和可扩展性的挑战对于实现iPSC疗法至关重要.

科学领域:

再生医学是一种再生医学.
干细胞生物学干细胞生物学
生物技术是生物技术.

背景情况:

诱导多能干细胞 (iPSCs) 对治疗诸如黄斑变性和神经退行性疾病等慢性疾病充满希望.
该iPSC治疗领域是新生的,涉及学术界,行业,监管机构和患者.
与传统疗法相比,iPSC疗法在安全性,功效,遗传稳定性,免疫性,瘤性,可再生性,可扩展性和移植性方面存在独特的挑战.

研究的目的:

审查阻碍iPSC技术临床应用的独特技术挑战.
提出潜在的解决方案,并确定 iPSC 疗法进步的关键领域.
涵盖重编程方法,遗传稳定性,分化,基因编辑,细胞疗法类型,监管方面和移植因素.

主要方法:

审查关于iPSC重编程,差异化和治疗应用的当前文献.
分析技术挑战,包括免疫性,瘤性,遗传稳定性和可扩展性.
探索潜在的解决方案,如基因编辑和优化生长因子使用.
讨论自主与异性细胞疗法,监管考虑和移植因素.

主要成果:

不同的iPSC重编程方法会影响免疫性和瘤性.
遗传不稳定性会影响细胞的再生能力和分化潜力.
增长因素和翻译后修改影响差异化和可扩展性.
基因编辑可能会增强iPSC分化.
自异性和异性疗法具有明显的优点和缺点.
调节途径和局部炎症影响细胞产品的活力和移植.

结论:

克服iPSC重编程,遗传稳定性,差异化和可扩展性的技术挑战对于治疗实现至关重要.
为了成功开发iPSC产品,必须仔细考虑细胞治疗类型,监管要求和植入因素.
需要进一步的研究和战略重点将iPSC的潜力转化为有效的细胞替代疗法.

更多相关视频

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Derivation of Adult Human Fibroblasts and their Direct Conversion into Expandable Neural Progenitor Cells

Published on: July 29, 2015

相关概念视频

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...